a

 

Communicable Diseases Department

 

Profile and Vision

 

Organogram

 

Emerging diseases: preparedness and response

 

Surveillance and Outbreak Alert

 

International Health Regulations

 

Laboratory support

 

Prevention & control of priority communicable diseases

 

HIV/AIDS    

 

Tuberculosis

 

Malaria

 

Transfusion transmitted infections

 

Elimination and eradication of tropical diseases

 

Leprosy

 

Dengue Fever

 

Lymphatic filariasis & Soil-transmitted Helminthiasis

 

Kala azar

 

Yaws

Communicable Diseases Department

Newsletters June 2007 Volume 4 Issue 2

Nipah Outbreak in India and Bangladesh

 

India

Between 11 and 28 April 2007, 30 cases of fever with acute respiratory distress and/or neurological symptoms were reported from Nadia district of West Bengal, Eastern India. The cases presented mainly with fever, headache and bodyache with a few cases having episodes of vomiting, disorientation, respiratory distress. Five cases ended fatally within 3-10 days of onset. Multidisciplinary teams carried out the outbreak investigation.

The epidemiological analysis of the five deaths showed that three cases belonged to Betai village (index case, wife and brother-close contacts), while two were from Krishnanagar town (also with history of close contact with index cases). Although the index case did not give any history of travel to Bangladesh, the border is just about 5 km away from the village, where an outbreak of Nipah virus was confirmed during the same period. Three samples (including urine, CSF, brain and lung tissue from postmortem) from the five fatal cases were found to be positive for Nipah Virus by RT-PCR. All these samples tested negative for flavivirus RNA including dengue.

A similar Nipah virus outbreak was first reported in India in Siliguri district, West Bengal with high mortality (74%) in January and February 2001 also following a similar outbreak in Bangladesh.

Dr Sampath Krishanan, WHO NPO, India

Bangladesh

Nipah outbreak was first documented in Bangladesh in 2001.  Then in January 2003, a similar outbreak was reported in Naogaon districtat a distance of 150 km from village reporting the first outbreak.  More recently two separate outbreaks in Thakurgaon and Kushtia were identified through a surveillance system set up in collaboration with the Institute of Epidemiology, Disease Control and Research (IEDCR) and ICDDRB.  In both situations, Nipah cases were defined as persons residing in the affected areas that have fever with new onset of seizures or altered neurological status.  The details are as follows.  The index case in Thakurgaon outbreak occurred in January and thereafter over a period of 4 weeks, 7 cases were reported out of which 3 died (case fatality rate=43%) of them were young adult males.  No occupational association can be established from available information.  Death occurred within 5-7 days of onset of disease.  (Fig. 2)

Thakurgaon outbreak: January-February 2007

The second outbreak in Khustia began in third week of March. 8 cases were reported out of which 5 were fatal (case fatality rate=62%). (Fig. 3) The mean age of cases was 38 years and most of the affected were females.  Most of the cases were rice firm workers.  All the cases were manifested with fever with a majority of them experiencing fatigue and weakness.  Neurological manifestations were found in 63% of cases.  On an average death occurred within 4 days of onset of disease.

 

Kushtia Outbreak:  March-April 2007

The data suggest strongly that infections were probably transmitted by close personal contact with the initial case.

Laboratory Investigations: Serum samples and throat swab have been taken from five cases in Thakurgaon CSF was also collected from one of the cases from Thakurgaon. In Kushtia serum samples, throat swab and nasal swab could be collected from only three of the cases. Samples were tested for IgM against Nipah Virus using Elisa method on priority basis in IEDCR laboratory.  All the serum and CSF samples (from Thakurgaon and Kushtia) were then shifted to CDC, Atlanta for reconfirmation.

Md Kamruzzaman Biswas, WHO, Bangladesh

 

 

| | | | | |